The global market for Biological Drugs was valued at US$ 340600 million in the year 2024 and is projected to reach a revised size of US$ 586860 million by 2031, growing at a CAGR of 8.2% during the forecast period.

Biological Drugs Market

The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Drugs.

The Biological Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biological Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biological Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Biological Drugs Market Report

Report Metric	Details
Report Name	Biological Drugs Market
Accounted market size in year	US$ 340600 million
Forecasted market size in 2031	US$ 586860 million
CAGR	8.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Therapeutic Protein Monoclonal Antibody Vaccine Others
Segment by Application	Hospitals Ambulatory Surgical Centers Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bristol-Myers Squibb, Eli Lilly, Takeda, Pfizer, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Merck, Abbott Laboratories, Baxter, Novartis, Biogen, GlaxoSmithKline
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biological Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biological Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Biological Drugs Market growing?

Ans: The Biological Drugs Market witnessing a CAGR of 8.2% during the forecast period 2025-2031.

What is the Biological Drugs Market size in 2031?

Ans: The Biological Drugs Market size in 2031 will be US$ 586860 million.

Who are the main players in the Biological Drugs Market report?

Ans: The main players in the Biological Drugs Market are Bristol-Myers Squibb, Eli Lilly, Takeda, Pfizer, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Merck, Abbott Laboratories, Baxter, Novartis, Biogen, GlaxoSmithKline

What are the Application segmentation covered in the Biological Drugs Market report?

Ans: The Applications covered in the Biological Drugs Market report are Hospitals, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Biological Drugs Market report?

Ans: The Types covered in the Biological Drugs Market report are Therapeutic Protein, Monoclonal Antibody, Vaccine, Others

1 Biological Drugs Market Overview

1.1 Product Definition

1.2 Biological Drugs by Type

1.2.1 Global Biological Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Therapeutic Protein

1.2.3 Monoclonal Antibody

1.2.4 Vaccine

1.2.5 Others

1.3 Biological Drugs by Application

1.3.1 Global Biological Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Global Biological Drugs Market Size Estimates and Forecasts

1.4.1 Global Biological Drugs Revenue 2020-2031

1.4.2 Global Biological Drugs Sales 2020-2031

1.4.3 Global Biological Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Biological Drugs Market Competition by Manufacturers

2.1 Global Biological Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Biological Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Biological Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Biological Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Biological Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Biological Drugs, Product Type & Application

2.7 Global Key Manufacturers of Biological Drugs, Date of Enter into This Industry

2.8 Global Biological Drugs Market Competitive Situation and Trends

2.8.1 Global Biological Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Biological Drugs Players Market Share by Revenue

2.8.3 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Biological Drugs Market Scenario by Region

3.1 Global Biological Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Biological Drugs Sales by Region: 2020-2031

3.2.1 Global Biological Drugs Sales by Region: 2020-2025

3.2.2 Global Biological Drugs Sales by Region: 2026-2031

3.3 Global Biological Drugs Revenue by Region: 2020-2031

3.3.1 Global Biological Drugs Revenue by Region: 2020-2025

3.3.2 Global Biological Drugs Revenue by Region: 2026-2031

3.4 North America Biological Drugs Market Facts & Figures by Country

3.4.1 North America Biological Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Biological Drugs Sales by Country (2020-2031)

3.4.3 North America Biological Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Biological Drugs Market Facts & Figures by Country

3.5.1 Europe Biological Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Biological Drugs Sales by Country (2020-2031)

3.5.3 Europe Biological Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Biological Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Biological Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Biological Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Biological Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Biological Drugs Market Facts & Figures by Country

3.7.1 Latin America Biological Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Biological Drugs Sales by Country (2020-2031)

3.7.3 Latin America Biological Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Biological Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Biological Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Biological Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Biological Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Biological Drugs Sales by Type (2020-2031)

4.1.1 Global Biological Drugs Sales by Type (2020-2025)

4.1.2 Global Biological Drugs Sales by Type (2026-2031)

4.1.3 Global Biological Drugs Sales Market Share by Type (2020-2031)

4.2 Global Biological Drugs Revenue by Type (2020-2031)

4.2.1 Global Biological Drugs Revenue by Type (2020-2025)

4.2.2 Global Biological Drugs Revenue by Type (2026-2031)

4.2.3 Global Biological Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Biological Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Biological Drugs Sales by Application (2020-2031)

5.1.1 Global Biological Drugs Sales by Application (2020-2025)

5.1.2 Global Biological Drugs Sales by Application (2026-2031)

5.1.3 Global Biological Drugs Sales Market Share by Application (2020-2031)

5.2 Global Biological Drugs Revenue by Application (2020-2031)

5.2.1 Global Biological Drugs Revenue by Application (2020-2025)

5.2.2 Global Biological Drugs Revenue by Application (2026-2031)

5.2.3 Global Biological Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Biological Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Bristol-Myers Squibb

6.1.1 Bristol-Myers Squibb Company Information

6.1.2 Bristol-Myers Squibb Description and Business Overview

6.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Bristol-Myers Squibb Biological Drugs Product Portfolio

6.1.5 Bristol-Myers Squibb Recent Developments/Updates

6.2 Eli Lilly

6.2.1 Eli Lilly Company Information

6.2.2 Eli Lilly Description and Business Overview

6.2.3 Eli Lilly Biological Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Eli Lilly Biological Drugs Product Portfolio

6.2.5 Eli Lilly Recent Developments/Updates

6.3 Takeda

6.3.1 Takeda Company Information

6.3.2 Takeda Description and Business Overview

6.3.3 Takeda Biological Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Takeda Biological Drugs Product Portfolio

6.3.5 Takeda Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Company Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer Biological Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pfizer Biological Drugs Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 Amgen

6.5.1 Amgen Company Information

6.5.2 Amgen Description and Business Overview

6.5.3 Amgen Biological Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Amgen Biological Drugs Product Portfolio

6.5.5 Amgen Recent Developments/Updates

6.6 F. Hoffmann-La Roche

6.6.1 F. Hoffmann-La Roche Company Information

6.6.2 F. Hoffmann-La Roche Description and Business Overview

6.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 F. Hoffmann-La Roche Biological Drugs Product Portfolio

6.6.5 F. Hoffmann-La Roche Recent Developments/Updates

6.7 Johnson & Johnson

6.7.1 Johnson & Johnson Company Information

6.7.2 Johnson & Johnson Description and Business Overview

6.7.3 Johnson & Johnson Biological Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Johnson & Johnson Biological Drugs Product Portfolio

6.7.5 Johnson & Johnson Recent Developments/Updates

6.8 Merck

6.8.1 Merck Company Information

6.8.2 Merck Description and Business Overview

6.8.3 Merck Biological Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Merck Biological Drugs Product Portfolio

6.8.5 Merck Recent Developments/Updates

6.9 Abbott Laboratories

6.9.1 Abbott Laboratories Company Information

6.9.2 Abbott Laboratories Description and Business Overview

6.9.3 Abbott Laboratories Biological Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Abbott Laboratories Biological Drugs Product Portfolio

6.9.5 Abbott Laboratories Recent Developments/Updates

6.10 Baxter

6.10.1 Baxter Company Information

6.10.2 Baxter Description and Business Overview

6.10.3 Baxter Biological Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Baxter Biological Drugs Product Portfolio

6.10.5 Baxter Recent Developments/Updates

6.11 Novartis

6.11.1 Novartis Company Information

6.11.2 Novartis Description and Business Overview

6.11.3 Novartis Biological Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Novartis Biological Drugs Product Portfolio

6.11.5 Novartis Recent Developments/Updates

6.12 Biogen

6.12.1 Biogen Company Information

6.12.2 Biogen Description and Business Overview

6.12.3 Biogen Biological Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Biogen Biological Drugs Product Portfolio

6.12.5 Biogen Recent Developments/Updates

6.13 GlaxoSmithKline

6.13.1 GlaxoSmithKline Company Information

6.13.2 GlaxoSmithKline Description and Business Overview

6.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 GlaxoSmithKline Biological Drugs Product Portfolio

6.13.5 GlaxoSmithKline Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Biological Drugs Industry Chain Analysis

7.2 Biological Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Biological Drugs Production Mode & Process Analysis

7.4 Biological Drugs Sales and Marketing

7.4.1 Biological Drugs Sales Channels

7.4.2 Biological Drugs Distributors

7.5 Biological Drugs Customer Analysis

8 Biological Drugs Market Dynamics

8.1 Biological Drugs Industry Trends

8.2 Biological Drugs Market Drivers

8.3 Biological Drugs Market Challenges

8.4 Biological Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Biological Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Biological Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Biological Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Biological Drugs Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global Biological Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Biological Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Biological Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Biological Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Biological Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Biological Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Biological Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Biological Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Biological Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Biological Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Biological Drugs Sales by Region (2020-2025) & (Units)

Table 18. Global Biological Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Biological Drugs Sales by Region (2026-2031) & (Units)

Table 20. Global Biological Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Biological Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Biological Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Biological Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Biological Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Biological Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Biological Drugs Sales by Country (2020-2025) & (Units)

Table 27. North America Biological Drugs Sales by Country (2026-2031) & (Units)

Table 28. North America Biological Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Biological Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Biological Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Biological Drugs Sales by Country (2020-2025) & (Units)

Table 32. Europe Biological Drugs Sales by Country (2026-2031) & (Units)

Table 33. Europe Biological Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Biological Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Biological Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Biological Drugs Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific Biological Drugs Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific Biological Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Biological Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Biological Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Biological Drugs Sales by Country (2020-2025) & (Units)

Table 42. Latin America Biological Drugs Sales by Country (2026-2031) & (Units)

Table 43. Latin America Biological Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Biological Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Biological Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Biological Drugs Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa Biological Drugs Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa Biological Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Biological Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Biological Drugs Sales (Units) by Type (2020-2025)

Table 51. Global Biological Drugs Sales (Units) by Type (2026-2031)

Table 52. Global Biological Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Biological Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Biological Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Biological Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Biological Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Biological Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Biological Drugs Price (USD/Unit) by Type (2020-2025)

Table 59. Global Biological Drugs Price (USD/Unit) by Type (2026-2031)

Table 60. Global Biological Drugs Sales (Units) by Application (2020-2025)

Table 61. Global Biological Drugs Sales (Units) by Application (2026-2031)

Table 62. Global Biological Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Biological Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Biological Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Biological Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Biological Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Biological Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Biological Drugs Price (USD/Unit) by Application (2020-2025)

Table 69. Global Biological Drugs Price (USD/Unit) by Application (2026-2031)

Table 70. Bristol-Myers Squibb Company Information

Table 71. Bristol-Myers Squibb Description and Business Overview

Table 72. Bristol-Myers Squibb Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Bristol-Myers Squibb Biological Drugs Product

Table 74. Bristol-Myers Squibb Recent Developments/Updates

Table 75. Eli Lilly Company Information

Table 76. Eli Lilly Description and Business Overview

Table 77. Eli Lilly Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Eli Lilly Biological Drugs Product

Table 79. Eli Lilly Recent Developments/Updates

Table 80. Takeda Company Information

Table 81. Takeda Description and Business Overview

Table 82. Takeda Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Takeda Biological Drugs Product

Table 84. Takeda Recent Developments/Updates

Table 85. Pfizer Company Information

Table 86. Pfizer Description and Business Overview

Table 87. Pfizer Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Pfizer Biological Drugs Product

Table 89. Pfizer Recent Developments/Updates

Table 90. Amgen Company Information

Table 91. Amgen Description and Business Overview

Table 92. Amgen Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Amgen Biological Drugs Product

Table 94. Amgen Recent Developments/Updates

Table 95. F. Hoffmann-La Roche Company Information

Table 96. F. Hoffmann-La Roche Description and Business Overview

Table 97. F. Hoffmann-La Roche Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. F. Hoffmann-La Roche Biological Drugs Product

Table 99. F. Hoffmann-La Roche Recent Developments/Updates

Table 100. Johnson & Johnson Company Information

Table 101. Johnson & Johnson Description and Business Overview

Table 102. Johnson & Johnson Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Johnson & Johnson Biological Drugs Product

Table 104. Johnson & Johnson Recent Developments/Updates

Table 105. Merck Company Information

Table 106. Merck Description and Business Overview

Table 107. Merck Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Merck Biological Drugs Product

Table 109. Merck Recent Developments/Updates

Table 110. Abbott Laboratories Company Information

Table 111. Abbott Laboratories Description and Business Overview

Table 112. Abbott Laboratories Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Abbott Laboratories Biological Drugs Product

Table 114. Abbott Laboratories Recent Developments/Updates

Table 115. Baxter Company Information

Table 116. Baxter Description and Business Overview

Table 117. Baxter Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Baxter Biological Drugs Product

Table 119. Baxter Recent Developments/Updates

Table 120. Novartis Company Information

Table 121. Novartis Description and Business Overview

Table 122. Novartis Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Novartis Biological Drugs Product

Table 124. Novartis Recent Developments/Updates

Table 125. Biogen Company Information

Table 126. Biogen Description and Business Overview

Table 127. Biogen Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Biogen Biological Drugs Product

Table 129. Biogen Recent Developments/Updates

Table 130. GlaxoSmithKline Company Information

Table 131. GlaxoSmithKline Description and Business Overview

Table 132. GlaxoSmithKline Biological Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. GlaxoSmithKline Biological Drugs Product

Table 134. GlaxoSmithKline Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Biological Drugs Distributors List

Table 138. Biological Drugs Customers List

Table 139. Biological Drugs Market Trends

Table 140. Biological Drugs Market Drivers

Table 141. Biological Drugs Market Challenges

Table 142. Biological Drugs Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Biological Drugs

Figure 2. Global Biological Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Biological Drugs Market Share by Type: 2024 & 2031

Figure 4. Therapeutic Protein Product Picture

Figure 5. Monoclonal Antibody Product Picture

Figure 6. Vaccine Product Picture

Figure 7. Others Product Picture

Figure 8. Global Biological Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Biological Drugs Market Share by Application: 2024 & 2031

Figure 10. Hospitals

Figure 11. Ambulatory Surgical Centers

Figure 12. Others

Figure 13. Global Biological Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Biological Drugs Market Size (2020-2031) & (US$ Million)

Figure 15. Global Biological Drugs Sales (2020-2031) & (Units)

Figure 16. Global Biological Drugs Average Price (USD/Unit) & (2020-2031)

Figure 17. Biological Drugs Report Years Considered

Figure 18. Biological Drugs Sales Share by Manufacturers in 2024

Figure 19. Global Biological Drugs Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Biological Drugs Players: Market Share by Revenue in Biological Drugs in 2024

Figure 21. Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Biological Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Biological Drugs Sales Market Share by Country (2020-2031)

Figure 24. North America Biological Drugs Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Biological Drugs Sales Market Share by Country (2020-2031)

Figure 28. Europe Biological Drugs Revenue Market Share by Country (2020-2031)

Figure 29. Germany Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Biological Drugs Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Biological Drugs Revenue Market Share by Region (2020-2031)

Figure 36. China Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Biological Drugs Sales Market Share by Country (2020-2031)

Figure 47. Latin America Biological Drugs Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Biological Drugs Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Biological Drugs Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Biological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Biological Drugs by Type (2020-2031)

Figure 57. Global Revenue Market Share of Biological Drugs by Type (2020-2031)

Figure 58. Global Biological Drugs Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Biological Drugs by Application (2020-2031)

Figure 60. Global Revenue Market Share of Biological Drugs by Application (2020-2031)

Figure 61. Global Biological Drugs Price (USD/Unit) by Application (2020-2031)

Figure 62. Biological Drugs Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions